Henry Meds
Isabelle Fymat is an accomplished financial executive with extensive experience in leadership roles across various industries. Currently serving as Chief Financial Officer at Henry Meds since April 2025, Isabelle has previously held the CFO position at Color from February 2021 to September 2024, where notable achievements included rebuilding a finance team and contributing to a $100M Series E fundraising round. Prior experience includes CFO roles at NPX Inc. and Whil, as well as serving as Consulting CFO for numerous startups. Educational qualifications include an MBA in Finance and Accounting from UCLA Anderson School of Management and a BA in Communications and Marketing from the University of Pennsylvania.
This person is not in any teams
This person is not in any offices
Henry Meds
4 followers
1/3rd of Americans cannot afford treatment for their chronic medical conditions. Henry delivers affordable treatment from $99/month.